眼科黏彈性器材市場：市場規模（按細分市場）、份額、監管、報銷、程序、預測（~2033）

眼科黏彈裝置又稱為OVD，是眼內手術中使用的裝置，主要由透明質酸鈉、硫酸軟骨素和羥丙基甲基纖維素組成。 這些裝置可以保護脆弱的眼部結構並減少角膜水腫等術後併發症。

OVD維持眼球前房壓力，維持眼球間隙，防止虹膜脫垂。 這些設備的使用顯著縮短了患者的復原時間。 常用於白內障手術，包括囊外手術及乳化手術。

眼科黏彈性裝置 (OVD) 在美國和歐洲市場有著悠久的使用歷史，在亞太和南美洲等新興市場也很成熟。

本報告詳細研究了全球眼科黏彈性器材市場，包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。

目錄

目前市面上的眼科黏彈裝置及競爭狀況

• 對主要產業趨勢的見解
• 2015 年至 2033 年眼科黏彈性器材各細分市場的市場總收入及市場前景
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域與國家見解

• 眼科黏彈裝置市場的SWOT分析
• 眼科黏彈性器材市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技的監管狀況

Abstract

Ophthalmic Viscoelastic Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Ophthalmic Viscoelastic Devices (OVD) market for the year 2020 and beyond. Ophthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery and are primary composed of sodium hyaluronate, chondroitin sulphate, or hydroxypropyl methylcellulose. These devices protect delicate ocular structures and reduce post operational complications such as corneal edema.

OVDs help maintain pressure in the anterior chamber of the eyes and prevent iris prolapse by maintaining compartmentalization of the eyes. The use of these devices significantly reduces patient recovery times. They are often used in cataract surgeries, including extracapsular and phacoemulsification surgeries.

Ophthalmic Viscoelastic Devices (OVD) have a long history of use in the US and European markets and are well established in emerging markets such as APAC and South America.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Ophthalmic Viscoelastic Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Ophthalmic Viscoelastic Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Ophthalmic Viscoelastic Devices market.
• Competitive dynamics insights and trends provided for Venous Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Carl Zeiss Stiftung AG, Bausch Health Companies Inc, Johnson & Johnson, Alcon Inc, CVC Capital Partners SICAV- FIS SA, Aurolab, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Ophthalmic Viscoelastic Devices (OVD) marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Ophthalmic Viscoelastic Devices (OVD).
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Ophthalmic Viscoelastic Devices (OVD).
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Ophthalmic Viscoelastic Devices (OVD) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Ophthalmic Viscoelastic Devices (OVD) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable